Roquefort Therapeutics (LON:ROQ) Stock Price Down 11.5%

Roquefort Therapeutics plc (LON:ROQ) shares were down 11.5% during trading on Friday . The company traded as low as GBX 3.61 ($0.05) and last traded at GBX 3.61 ($0.05). Approximately 567,072 shares traded hands during trading, an increase of 85% from the average daily volume of 306,677 shares. The stock had previously closed at GBX 4.08 ($0.05).

Roquefort Therapeutics Price Performance

The stock has a market capitalization of £4.66 million, a PE ratio of -374.00 and a beta of 0.09. The firm has a fifty day moving average price of GBX 4.37 and a two-hundred day moving average price of GBX 5.38.

About Roquefort Therapeutics

Roquefort Therapeutics plc, a biotechnology company, engages in the development of medicines for the treatment of cancer. The company's pre-clinical development pipeline comprises Midkine antibodies with significance in vivo efficacy and toxicology studies; Midkine RNA therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics with novel anti-cancer approach; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and NK-mediated anti-cancer action.